These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 17493183

  • 1. Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia.
    Paladino JA, Eubanks DA, Adelman MH, Schentag JJ.
    J Am Geriatr Soc; 2007 May; 55(5):651-7. PubMed ID: 17493183
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG, Graham MR, Lindsey CC, Lamp KC, Freeman C, Glaros A.
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [Abstract] [Full Text] [Related]

  • 3. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
    Welte T, Petermann W, Schürmann D, Bauer TT, Reimnitz P, MOXIRAPID Study Group.
    Clin Infect Dis; 2005 Dec 15; 41(12):1697-705. PubMed ID: 16288390
    [Abstract] [Full Text] [Related]

  • 4. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC, MOTIV (MOxifloxacin Treatment IV) Study Group.
    Clin Infect Dis; 2008 May 15; 46(10):1499-509. PubMed ID: 18419482
    [Abstract] [Full Text] [Related]

  • 5. Extended-interval gentamicin administration in malnourished children.
    Khan AM, Ahmed T, Alam NH, Chowdhury AK, Fuchs GJ.
    J Trop Pediatr; 2006 Jun 15; 52(3):179-84. PubMed ID: 16126804
    [Abstract] [Full Text] [Related]

  • 6. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S, Kollaras P, Giannakakis T, Seitanidis B, Kordosis T, Nikolaidis J, Hatzitolios A, Nikolaidis P.
    Eur J Intern Med; 2008 Dec 15; 19(8):619-24. PubMed ID: 19046729
    [Abstract] [Full Text] [Related]

  • 7. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
    Ortiz-Ruiz G, Caballero-Lopez J, Friedland IR, Woods GL, Carides A, Protocol 018 Ertapenem Community-Acquired Pneumonia Study Group.
    Clin Infect Dis; 2002 Apr 15; 34(8):1076-83. PubMed ID: 11914996
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of oral gemifloxacin versus intravenous ceftriaxone followed by oral cefuroxime with/without a macrolide for the treatment of hospitalized patients with community-acquired pneumonia.
    Bhavnani SM, Ambrose PG.
    Diagn Microbiol Infect Dis; 2008 Jan 15; 60(1):59-64. PubMed ID: 17889491
    [Abstract] [Full Text] [Related]

  • 9. Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
    Yakovlev SV, Stratchounski LS, Woods GL, Adeyi B, McCarroll KA, Ginanni JA, Friedland IR, Wood CA, DiNubile MJ.
    Eur J Clin Microbiol Infect Dis; 2006 Oct 15; 25(10):633-41. PubMed ID: 17024505
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
    Bijie H, Kulpradist S, Manalaysay M, Soebandrio A.
    J Chemother; 2005 Feb 15; 17(1):3-24. PubMed ID: 15828439
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb 15; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 13. Ceftriaxone is twice as cost-effective as standard therapy in biliary tract infection.
    Zoepf T, Jakobs R, Riemann JF.
    Hepatogastroenterology; 2004 Feb 15; 51(58):941-5. PubMed ID: 15239219
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of nursing home-acquired pneumonia.
    Mills K, Graham AC, Winslow BT, Springer KL.
    Am Fam Physician; 2009 Jun 01; 79(11):976-82. PubMed ID: 19514695
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG, Woods GL, Jiang Q, Gesser RM.
    J Antimicrob Chemother; 2004 Jun 01; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [Abstract] [Full Text] [Related]

  • 18. The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home-acquired pneumonia.
    Phillips SL, Branaman-Phillips J.
    J Am Geriatr Soc; 1993 Oct 01; 41(10):1071-4. PubMed ID: 8409152
    [Abstract] [Full Text] [Related]

  • 19. The cost of treating pneumonia in the nursing home setting.
    Kruse RL, Boles KE, Mehr DR, Spalding D, Lave JR.
    J Am Med Dir Assoc; 2003 Oct 01; 4(2):81-9. PubMed ID: 12807579
    [Abstract] [Full Text] [Related]

  • 20. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.
    File TM, Low DE, Eckburg PB, Talbot GH, Friedland HD, Lee J, Llorens L, Critchley I, Thye D.
    Clin Infect Dis; 2010 Dec 15; 51(12):1395-405. PubMed ID: 21067350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.